(19)
(11) EP 1 003 870 A1

(12)

(43) Date of publication:
31.05.2000 Bulletin 2000/22

(21) Application number: 98930967.9

(22) Date of filing: 16.07.1998
(51) International Patent Classification (IPC)7C12N 15/31, C07K 14/35, C12N 15/62, C07K 19/00, C12N 15/74, G01N 33/53, C12N 1/21, C07K 16/12, A61K 39/04, C12Q 1/68
// (C12N1/21, C12R1:32, 1:19, 1:34, 1:38), C12R1:42
(86) International application number:
PCT/IB9801/091
(87) International publication number:
WO 9904/005 (28.01.1999 Gazette 1999/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 16.07.1997 US 52631 P

(71) Applicants:
  • INSTITUT PASTEUR
    75015 Paris (FR)
  • Statens Serum Institut
    2300 Copenhagen 5 (DK)

(72) Inventors:
  • GICQUEL, Brigitte
    F-75014 Paris (FR)
  • BERTHET, François-Xavier
    F-75015 Paris (FR)
  • ANDERSEN, Peter
    DK-2700 Brönshöj (DK)
  • RASMUSSEN, Peter, Birk
    DK-2100 Köbenhavn (DK)

(74) Representative: Warcoin, Jacques et al
Cabinet Régimbeau,26, avenue Kléber
75116 Paris
75116 Paris (FR)

   


(54) A POLYNUCLEOTIDE FUNCTIONALLY CODING FOR THE LHP PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS, ITS BIOLOGICALLY ACTIVE DERIVATIVE FRAGMENTS, AS WELL AS METHODS USING THE SAME